Biogen Whistleblower's $250M Award 'Extraordinary' For FCA
A former pharmaceutical manager's $250 million cut of Biogen's $900 million payments-for-prescriptions settlement is among the largest whistleblower awards in U.S. history, delivering a shot of adrenaline to other False Claims...To view the full article, register now.
Already a subscriber? Click here to view full article